0.9(top 50%)
impact factor
5.4K(top 5%)
papers
65.4K(top 5%)
citations
80(top 10%)
h-index
0.9(top 50%)
impact factor
5.6K
all documents
67.5K
doc citations
114(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Platelet sizeBlood Coagulation and Fibrinolysis1996646
2Multi-centre investigation on reference ranges for ROTEM thromboelastometryBlood Coagulation and Fibrinolysis2005441
3Statistica for WindowsBlood Coagulation and Fibrinolysis1995351
4ThrombelastographyBlood Coagulation and Fibrinolysis2001273
5Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatranBlood Coagulation and Fibrinolysis2012248
6The platelet glycoprotein Ib???IX complexBlood Coagulation and Fibrinolysis1994238
7Platelet size: measurement, physiology and vascular diseaseBlood Coagulation and Fibrinolysis1996238
8Prevention of venous thromboembolism in medical patients with enoxaparinBlood Coagulation and Fibrinolysis2003224
9Clinical experience with recombinant factor VIIaBlood Coagulation and Fibrinolysis1998205
10PlasminogenBlood Coagulation and Fibrinolysis1992200
11AntithrombinBlood Coagulation and Fibrinolysis2002191
12Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxisBlood Coagulation and Fibrinolysis2003167
13Update on von Willebrand factor multimersBlood Coagulation and Fibrinolysis2014166
14Performance of the platelet function analyser PFA-100?? in testing abnormalities of primary haemostasisBlood Coagulation and Fibrinolysis1999157
15The effect of recombinant factor VIIa (NovoSeven???) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0Blood Coagulation and Fibrinolysis1998155
16The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjectsBlood Coagulation and Fibrinolysis1994153
17Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgeryBlood Coagulation and Fibrinolysis2000151
18Stability of coagulation proteins in frozen plasmaBlood Coagulation and Fibrinolysis2001150
19Effects of serotonin on platelet activation in whole bloodBlood Coagulation and Fibrinolysis1997146
20The effects of alcohol on coagulation and fibrinolytic factorsBlood Coagulation and Fibrinolysis1998144
21NovoSeven® as a universal haemostatic agentBlood Coagulation and Fibrinolysis2000140
22Tissue factor pathway inhibitor and the current concept of blood coagulationBlood Coagulation and Fibrinolysis1995133
23Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complicationsBlood Coagulation and Fibrinolysis2002128
24Thrombin structure and functionBlood Coagulation and Fibrinolysis1991127
25Effect of fibrin structure on plasmin-mediated dissolution of plasma clotsBlood Coagulation and Fibrinolysis1995126
26A murine model of factor XI deficiencyBlood Coagulation and Fibrinolysis1997126
27Venous and arterial thrombosis following administration of intravenous immunoglobulinsBlood Coagulation and Fibrinolysis2005124
28Factor VIIa in the treatment of haemophiliaBlood Coagulation and Fibrinolysis1990121
29Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms?Blood Coagulation and Fibrinolysis2000115
30A comparison of the Thrombelastograph and the ROTEMBlood Coagulation and Fibrinolysis2007113
31Platelets, coagulation, and fibrinolysis in sickle cell diseaseBlood Coagulation and Fibrinolysis1991110
32Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulationBlood Coagulation and Fibrinolysis2003109
33Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulationBlood Coagulation and Fibrinolysis2009108
34Hereditary deficiency of antithrombin III, protein C and protein SBlood Coagulation and Fibrinolysis1992106
35Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopeniaBlood Coagulation and Fibrinolysis1997106
36Long-term prophylaxis in von Willebrand diseaseBlood Coagulation and Fibrinolysis2005106
37Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplastyBlood Coagulation and Fibrinolysis2014103
38Thromboelastography with citrated bloodBlood Coagulation and Fibrinolysis2004102
39Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpuraBlood Coagulation and Fibrinolysis2006102
40Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapyBlood Coagulation and Fibrinolysis2006102
41What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studiesBlood Coagulation and Fibrinolysis2019101
42Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometryBlood Coagulation and Fibrinolysis1994100
43Transmission of a procoagulant signal from tissue factor-bearing cells to plateletsBlood Coagulation and Fibrinolysis1996100
44Thromboelastography: a reliable test?Blood Coagulation and Fibrinolysis200199
45Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastographyBlood Coagulation and Fibrinolysis200798
46The present status of tissue factor pathway inhibitorBlood Coagulation and Fibrinolysis199297
47Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatmentBlood Coagulation and Fibrinolysis199697
48International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patientsBlood Coagulation and Fibrinolysis200697
49Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing??s syndromeBlood Coagulation and Fibrinolysis199996
50Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovaleBlood Coagulation and Fibrinolysis200395